Skip to content

Biogen

NASDAQ: BIIB · USD

Biogen financials

6 charts

Revenue

USD millions

$2,736M
Biogen Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2009 Q2$1,093.289M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$1,120.518M; +2.5% vs FY 2009 Q2
FY 2009 Q4$1,127M; +0.6% vs FY 2009 Q3
FY 2010 Q1$1,108.86M; −1.6% vs FY 2009 Q4
FY 2010 Q2$1,212.702M; +9.4% vs FY 2010 Q1
FY 2010 Q3$1,175.789M; −3.0% vs FY 2010 Q2
FY 2010 Q4$1,219M; +3.7% vs FY 2010 Q3
FY 2011 Q1$1,203.342M; −1.3% vs FY 2010 Q4
FY 2011 Q2$1,208.647M; +0.4% vs FY 2011 Q1
FY 2011 Q3$1,309.934M; +8.4% vs FY 2011 Q2
FY 2011 Q4$1,326.7M; +1.3% vs FY 2011 Q3
FY 2012 Q1$1,292.014M; −2.6% vs FY 2011 Q4
FY 2012 Q2$1,420.951M; +10.0% vs FY 2012 Q1
FY 2012 Q3$1,385.554M; −2.5% vs FY 2012 Q2
FY 2012 Q4$1,417.9M; +2.3% vs FY 2012 Q3
FY 2013 Q1$1,415.096M; −0.2% vs FY 2012 Q4
FY 2013 Q2$1,723.473M; +21.8% vs FY 2013 Q1
FY 2013 Q3$1,827.78M; +6.1% vs FY 2013 Q2
FY 2013 Q4$1,965.9M; +7.6% vs FY 2013 Q3
FY 2014 Q1$2,129.751M; +8.3% vs FY 2013 Q4
FY 2014 Q2$2,421.452M; +13.7% vs FY 2014 Q1
FY 2014 Q3$2,511.446M; +3.7% vs FY 2014 Q2
FY 2014 Q4$2,640.7M; +5.1% vs FY 2014 Q3
FY 2015 Q1$2,554.963M; −3.2% vs FY 2014 Q4
FY 2015 Q2$2,591.642M; +1.4% vs FY 2015 Q1
FY 2015 Q3$2,777.859M; +7.2% vs FY 2015 Q2
FY 2015 Q4$2,839.3M; +2.2% vs FY 2015 Q3
FY 2016 Q1$2,726.8M; −4.0% vs FY 2015 Q4
FY 2016 Q2$2,894.2M; +6.1% vs FY 2016 Q1
FY 2016 Q3$2,955.8M; +2.1% vs FY 2016 Q2
FY 2016 Q4$2,872M; −2.8% vs FY 2016 Q3
FY 2017 Q1$2,810.7M; −2.1% vs FY 2016 Q4
FY 2017 Q2$3,078.4M; +9.5% vs FY 2017 Q1
FY 2017 Q3$3,077.8M; 0.0% vs FY 2017 Q2
FY 2017 Q4$3,307M; +7.4% vs FY 2017 Q3
FY 2018 Q1$3,131.1M; −5.3% vs FY 2017 Q4
FY 2018 Q2$3,356.5M; +7.2% vs FY 2018 Q1
FY 2018 Q3$3,439M; +2.5% vs FY 2018 Q2
FY 2018 Q4$3,526.3M; +2.5% vs FY 2018 Q3
FY 2019 Q1$3,489.8M; −1.0% vs FY 2018 Q4
FY 2019 Q2$3,616.7M; +3.6% vs FY 2019 Q1
FY 2019 Q3$3,600.1M; −0.5% vs FY 2019 Q2
FY 2019 Q4$3,671.3M; +2.0% vs FY 2019 Q3
FY 2020 Q1$3,534.3M; −3.7% vs FY 2019 Q4
FY 2020 Q2$3,681.6M; +4.2% vs FY 2020 Q1
FY 2020 Q3$3,376.1M; −8.3% vs FY 2020 Q2
FY 2020 Q4$2,852.6M; −15.5% vs FY 2020 Q3
FY 2021 Q1$2,694M; −5.6% vs FY 2020 Q4
FY 2021 Q2$2,775M; +3.0% vs FY 2021 Q1
FY 2021 Q3$2,778.9M; +0.1% vs FY 2021 Q2
FY 2021 Q4$2,733.8M; −1.6% vs FY 2021 Q3
FY 2022 Q1$2,589.1M; −5.3% vs FY 2021 Q4
FY 2022 Q3$2,508.5M; Change unavailable vs FY 2022 Q2
FY 2022 Q4$2,544M; +1.4% vs FY 2022 Q3
FY 2023 Q1$2,463M; −3.2% vs FY 2022 Q4
FY 2023 Q2$2,456M; −0.3% vs FY 2023 Q1
FY 2023 Q3$2,530.3M; +3.0% vs FY 2023 Q2
FY 2023 Q4$2,386.3M; −5.7% vs FY 2023 Q3
FY 2024 Q1$2,290.5M; −4.0% vs FY 2023 Q4
FY 2024 Q2$2,464.9M; +7.6% vs FY 2024 Q1
FY 2024 Q3$2,465.8M; 0.0% vs FY 2024 Q2
FY 2024 Q4$2,454.7M; −0.5% vs FY 2024 Q3
FY 2025 Q1$2,431M; −1.0% vs FY 2024 Q4
FY 2025 Q2$2,645.5M; +8.8% vs FY 2025 Q1
FY 2025 Q3$2,534.7M; −4.2% vs FY 2025 Q2
FY 2025 Q4$2,279.4M; −10.1% vs FY 2025 Q3
FY 2026 Q1$2,477.8M; +8.7% vs FY 2025 Q4
FY 2026 Q2$2,736M; +10.4% vs FY 2026 Q1
Jun 30, 2009 through Sep 25, 2026

Free cash flow

USD millions

$408M
Biogen Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2009 Q2$119.789M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$81.575M; −31.9% vs FY 2009 Q2
FY 2009 Q4$226.655M; +177.8% vs FY 2009 Q3
FY 2010 Q1$298.686M; +31.8% vs FY 2009 Q4
FY 2010 Q2$381.43M; +27.7% vs FY 2010 Q1
FY 2010 Q3$389.281M; +2.1% vs FY 2010 Q2
FY 2010 Q4$382.221M; −1.8% vs FY 2010 Q3
FY 2011 Q1$221.435M; −42.1% vs FY 2010 Q4
FY 2011 Q2$375.58M; +69.6% vs FY 2011 Q1
FY 2011 Q3$519.174M; +38.2% vs FY 2011 Q2
FY 2011 Q4$403.532M; −22.3% vs FY 2011 Q3
FY 2012 Q1$140.074M; −65.3% vs FY 2011 Q4
FY 2012 Q2$562.685M; +301.7% vs FY 2012 Q1
FY 2012 Q3$483.72M; −14.0% vs FY 2012 Q2
FY 2012 Q4$438.87M; −9.3% vs FY 2012 Q3
FY 2013 Q1$145.65M; −66.8% vs FY 2012 Q4
FY 2013 Q2$571.061M; +292.1% vs FY 2013 Q1
FY 2013 Q3$591.734M; +3.6% vs FY 2013 Q2
FY 2013 Q4$790.352M; +33.6% vs FY 2013 Q3
FY 2014 Q1$50.32M; −93.6% vs FY 2013 Q4
FY 2014 Q2$926.591M; +1741.4% vs FY 2014 Q1
FY 2014 Q3$851.487M; −8.1% vs FY 2014 Q2
FY 2014 Q4$825.966M; −3.0% vs FY 2014 Q3
FY 2015 Q1$635.207M; −23.1% vs FY 2014 Q4
FY 2015 Q2$917.362M; +44.4% vs FY 2015 Q1
FY 2015 Q3$666.251M; −27.4% vs FY 2015 Q2
FY 2015 Q4$854.28M; +28.2% vs FY 2015 Q3
FY 2016 Q1$836.5M; −2.1% vs FY 2015 Q4
FY 2016 Q2$859M; +2.7% vs FY 2016 Q1
FY 2016 Q3$816.3M; −5.0% vs FY 2016 Q2
FY 2016 Q4$1,394.5M; +70.8% vs FY 2016 Q3
FY 2017 Q1$25.2M; −98.2% vs FY 2016 Q4
FY 2017 Q2$971.5M; +3755.2% vs FY 2017 Q1
FY 2017 Q3$1,399.2M; +44.0% vs FY 2017 Q2
FY 2017 Q4$1,287.7M; −8.0% vs FY 2017 Q3
FY 2018 Q1$1,262.4M; −2.0% vs FY 2017 Q4
FY 2018 Q2$912.5M; −27.7% vs FY 2018 Q1
FY 2018 Q3$1,572.7M; +72.4% vs FY 2018 Q2
FY 2018 Q4$1,669.5M; +6.2% vs FY 2018 Q3
FY 2019 Q1$1,332.4M; −20.2% vs FY 2018 Q4
FY 2019 Q2$1,777.1M; +33.4% vs FY 2019 Q1
FY 2019 Q3$1,604.8M; −9.7% vs FY 2019 Q2
FY 2019 Q4$1,849.8M; +15.3% vs FY 2019 Q3
FY 2020 Q1$1,317.6M; −28.8% vs FY 2019 Q4
FY 2020 Q2$1,843.5M; +39.9% vs FY 2020 Q1
FY 2020 Q3$1,097M; −40.5% vs FY 2020 Q2
FY 2020 Q4$-453.1M; −141.3% vs FY 2020 Q3
FY 2021 Q1$676.4M; +249.3% vs FY 2020 Q4
FY 2021 Q2$1,155.4M; +70.8% vs FY 2021 Q1
FY 2021 Q3$763.3M; −33.9% vs FY 2021 Q2
FY 2021 Q4$786.7M; +3.1% vs FY 2021 Q3
FY 2022 Q1$699.6M; −11.1% vs FY 2021 Q4
FY 2022 Q3$601.9M; Change unavailable vs FY 2022 Q2
FY 2022 Q4$-261.4M; −143.4% vs FY 2022 Q3
FY 2023 Q1$388.7M; +248.7% vs FY 2022 Q4
FY 2023 Q2$416M; +7.0% vs FY 2023 Q1
FY 2023 Q3$518.2M; +24.6% vs FY 2023 Q2
FY 2023 Q4$-52.7M; −110.2% vs FY 2023 Q3
FY 2024 Q1$507.3M; +1062.6% vs FY 2023 Q4
FY 2024 Q2$592.3M; +16.8% vs FY 2024 Q1
FY 2024 Q3$900.6M; +52.1% vs FY 2024 Q2
FY 2024 Q4$721.6M; −19.9% vs FY 2024 Q3
FY 2025 Q1$222.2M; −69.2% vs FY 2024 Q4
FY 2025 Q2$134.3M; −39.6% vs FY 2025 Q1
FY 2025 Q3$1,226.3M; +813.1% vs FY 2025 Q2
FY 2025 Q4$468M; −61.8% vs FY 2025 Q3
FY 2026 Q1$594.3M; +27.0% vs FY 2025 Q4
FY 2026 Q2$408M; −31.3% vs FY 2026 Q1

Net margin

%

3.56%
Biogen Net margin. Reported fiscal history.
Fiscal period%
FY 2009 Q213.07%
FY 2009 Q324.78%
FY 2009 Q427.12%
FY 2010 Q119.61%
FY 2010 Q224.2%
FY 2010 Q321.61%
FY 2010 Q419.71%
FY 2011 Q124.46%
FY 2011 Q223.83%
FY 2011 Q326.86%
FY 2011 Q422.63%
FY 2012 Q123.43%
FY 2012 Q227.22%
FY 2012 Q328.75%
FY 2012 Q420.6%
FY 2013 Q130.16%
FY 2013 Q228.47%
FY 2013 Q326.68%
FY 2013 Q423.26%
FY 2014 Q122.54%
FY 2014 Q229.51%
FY 2014 Q334.12%
FY 2014 Q433.46%
FY 2015 Q132.19%
FY 2015 Q235.78%
FY 2015 Q334.76%
FY 2015 Q429.29%
FY 2016 Q135.61%
FY 2016 Q236.27%
FY 2016 Q334.94%
FY 2016 Q422.6%
FY 2017 Q126.6%
FY 2017 Q228.03%
FY 2017 Q339.84%
FY 2017 Q4-8.99%
FY 2018 Q137.46%
FY 2018 Q225.82%
FY 2018 Q342%
FY 2018 Q426.85%
FY 2019 Q140.37%
FY 2019 Q241.31%
FY 2019 Q342.94%
FY 2019 Q439.21%
FY 2020 Q139.59%
FY 2020 Q241.89%
FY 2020 Q320.78%
FY 2020 Q412.55%
FY 2021 Q115.23%
FY 2021 Q216.16%
FY 2021 Q311.85%
FY 2021 Q413.47%
FY 2022 Q140.86%
FY 2022 Q345.23%
FY 2022 Q421.64%
FY 2023 Q115.75%
FY 2023 Q224.09%
FY 2023 Q3-2.69%
FY 2023 Q410.46%
FY 2024 Q117.18%
FY 2024 Q223.68%
FY 2024 Q315.76%
FY 2024 Q410.86%
FY 2025 Q19.89%
FY 2025 Q224%
FY 2025 Q318.4%
FY 2025 Q4-2.15%
FY 2026 Q112.89%
FY 2026 Q23.56%

P/E

× · TTM · Daily

40.55×
Biogen P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2011-02-2816.56×2010-12-31
2011-03-3117.79×2010-12-31
2011-04-2922.1×2011-03-31
2011-05-3121.44×2011-03-31
2011-06-3024.2×2011-03-31
2011-07-2923.2×2011-06-30
2011-08-3121.45×2011-06-30
2011-09-3021.21×2011-06-30
2011-10-3124.32×2011-09-30
2011-11-3024.03×2011-09-30
2011-12-3023×2011-09-30
2012-01-3124.65×2011-09-30
2012-02-2924.34×2011-09-30
2012-03-3026.34×2011-09-30
2012-04-3028.01×2011-09-30
2012-05-3127.33×2011-09-30
2012-06-2930.18×2011-09-30
2012-07-3130.48×2011-09-30
2012-08-3130.64×2011-09-30
2012-09-2831.19×2011-09-30
2012-10-3128.89×2011-09-30
2012-11-3031.16×2011-09-30
2012-12-3130.59×2011-09-30
2013-01-3132.62×2011-09-30
2013-02-2834.77×2011-09-30
2013-03-2840.26×2011-09-30
2013-04-3045.76×2011-09-30
2013-05-3149.64×2011-09-30
2013-06-2844.98×2011-09-30
2013-07-3145.59×2011-09-30
2013-08-3044.52×2011-09-30
2013-09-3050.32×2011-09-30
2013-10-3151.04×2011-09-30
2013-11-2960.82×2011-09-30
2013-12-3158.44×2011-09-30
2014-01-3165.35×2011-09-30
2014-02-2843.49×2013-12-31
2014-03-3139.04×2013-12-31
2014-04-3035.65×2014-03-31
2014-05-3039.66×2014-03-31
2014-06-3039.15×2014-03-31
2014-07-3141.52×2014-03-31
2014-08-2942.59×2014-03-31
2014-09-3041.08×2014-03-31
2014-10-3139.87×2014-03-31
2014-11-2838.21×2014-03-31
2014-12-3142.15×2014-03-31
2015-01-3048.32×2014-03-31
2015-02-2750.86×2014-03-31
2015-03-3152.43×2014-03-31
2015-04-3046.43×2014-03-31
2015-05-2949.29×2014-03-31
2015-06-3050.16×2014-03-31
2015-07-3135.37×2014-06-30
2015-08-3132.99×2014-06-30
2015-09-3032.38×2014-06-30
2015-10-3027.44×2014-09-30
2015-11-3027.1×2014-09-30
2015-12-3128.94×2014-09-30
2016-01-2925.79×2014-09-30
2016-02-2920.89×2014-12-31
2016-03-3120.96×2014-12-31
2016-04-2917.77×2015-09-30
2016-05-3118.73×2015-09-30
2016-06-3015.63×2015-09-30
2016-07-2918.74×2015-09-30
2016-08-3119.75×2015-09-30
2016-09-3020.23×2015-09-30
2016-10-3118.11×2015-09-30
2016-11-3019.01×2015-09-30
2016-12-3018.33×2015-09-30
2017-01-3117.92×2015-09-30
2017-02-2818.65×2015-09-30
2017-03-3117.67×2015-09-30
2017-04-2817.53×2015-09-30
2017-05-3116.01×2015-09-30
2017-06-3017.54×2015-09-30
2017-07-3118.72×2015-09-30
2017-08-3120.46×2015-09-30
2017-09-2920.24×2015-09-30
2017-10-3120.14×2015-09-30
2017-11-3020.82×2015-09-30
2017-12-2920.59×2015-09-30
2018-01-3122.48×2015-09-30
2018-02-2824.13×2017-12-31
2018-03-2922.86×2017-12-31
2018-04-3022.84×2017-12-31
2018-05-3124.54×2017-12-31
2018-06-2924.23×2017-12-31
2018-07-3127.92×2017-12-31
2018-08-3129.51×2017-12-31
2018-09-2829.5×2017-12-31
2018-10-3125.4×2017-12-31
2018-11-3027.86×2017-12-31
2018-12-3125.13×2017-12-31
2019-01-3127.87×2017-12-31
2019-02-2814.83×2018-12-31
2019-03-2910.69×2018-12-31
2019-04-3010.36×2018-12-31
2019-05-319.91×2018-12-31
2019-06-2810.57×2018-12-31
2019-07-3110.75×2018-12-31
2019-08-309.93×2018-12-31
2019-09-3010.53×2018-12-31
2019-10-3110.2×2019-09-30
2019-11-2910.24×2019-09-30
2019-12-3110.13×2019-09-30
2020-01-319.18×2019-09-30
2020-02-289.33×2019-12-31
2020-03-319.57×2019-12-31
2020-04-308.74×2020-03-31
2020-05-299.04×2020-03-31
2020-06-307.88×2020-03-31
2020-07-317.46×2020-06-30
2020-08-317.81×2020-06-30
2020-09-307.7×2020-06-30
2020-10-307.8×2020-09-30
2020-11-307.43×2020-09-30
2020-12-317.57×2020-09-30
2021-01-298.74×2020-09-30
2021-02-2610.5×2020-12-31
2021-03-3110.77×2020-12-31
2021-04-3013.52×2021-03-31
2021-05-2813.53×2021-03-31
2021-06-3017.51×2021-03-31
2021-07-3025.57×2021-06-30
2021-08-3126.52×2021-06-30
2021-09-3022.15×2021-06-30
2021-10-2925.64×2021-09-30
2021-11-3022.66×2021-09-30
2021-12-3123.06×2021-09-30
2022-01-3121.73×2021-09-30
2022-02-2820×2021-12-31
2022-03-3119.97×2021-12-31
2022-04-2919.67×2021-12-31
2022-05-3118.96×2021-12-31
2022-06-3019.33×2021-12-31
2022-07-2920.39×2021-12-31
2022-08-3118.52×2021-12-31
2022-09-3025.31×2021-12-31
2022-10-3114.33×2022-09-30
2022-11-3015.43×2022-09-30
2022-12-3014×2022-09-30
2023-01-3114.7×2022-09-30
2023-02-2812.88×2022-12-31
2023-03-3113.27×2022-12-31
2023-04-2814.52×2022-12-31
2023-05-3114.15×2022-12-31
2023-06-3013.59×2022-12-31
2023-07-3114.75×2023-06-30
2023-08-3114.6×2023-06-30
2023-09-2914.03×2023-06-30
2023-10-3112.97×2023-06-30
2023-11-3023.19×2023-09-30
2023-12-2925.63×2023-09-30
2024-01-3124.43×2023-09-30
2024-02-2927.27×2023-12-31
2024-03-2827.09×2023-12-31
2024-04-3026.87×2024-03-31
2024-05-3128.13×2024-03-31
2024-06-2828.99×2024-03-31
2024-07-3126.66×2024-03-31
2024-08-3025.61×2024-03-31
2024-09-3024.24×2024-03-31
2024-10-3121.76×2024-03-31
2024-11-2920.09×2024-03-31
2024-12-3119.12×2024-03-31
2025-01-3118×2024-03-31
2025-02-2812.53×2024-12-31
2025-03-3112.21×2024-12-31
2025-04-3010.8×2024-12-31
2025-05-3011.58×2024-12-31
2025-06-3011.2×2024-12-31
2025-07-3111.42×2024-12-31
2025-08-2911.79×2024-12-31
2025-09-3012.5×2024-12-31
2025-10-3113.76×2024-12-31
2025-11-2816.24×2024-12-31
2025-12-3115.7×2024-12-31
2026-01-3016.05×2024-12-31
2026-02-2721.96×2025-12-31
2026-03-3120.98×2025-12-31
2026-04-3020.47×2026-03-31
2026-05-2921.2×2026-03-31
2026-06-3023.37×2026-03-31
2026-07-3136.16×2026-06-30
2026-08-3138.6×2026-06-30
2026-09-2540.55×2026-06-30
Mean 23.68×Median 21.39×90% above median

ROIC

% · Annual / TTM

—
Biogen ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2009 Q2—
FY 2009 Q3—
FY 2009 Q4—
FY 2010 Q1—
FY 2010 Q2—
FY 2010 Q3—
FY 2010 Q4—
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q420.17%
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q419.3%
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q423.79%
FY 2014 Q1—
FY 2014 Q224.84%
FY 2014 Q328.02%
FY 2014 Q432.66%
FY 2015 Q133.71%
FY 2015 Q233.41%
FY 2015 Q332.39%
FY 2015 Q441.79%
FY 2016 Q129.24%
FY 2016 Q228.33%
FY 2016 Q327.5%
FY 2016 Q443.08%
FY 2017 Q122.51%
FY 2017 Q220.95%
FY 2017 Q321.51%
FY 2017 Q426.69%
FY 2018 Q119.87%
FY 2018 Q219.52%
FY 2018 Q319.56%
FY 2018 Q431.04%
FY 2019 Q126.55%
FY 2019 Q230.16%
FY 2019 Q332.19%
FY 2019 Q436.15%
FY 2020 Q1—
FY 2020 Q2—
FY 2020 Q3—
FY 2020 Q4—
FY 2021 Q1—
FY 2021 Q2—
FY 2021 Q3—
FY 2021 Q4—
FY 2022 Q1—
FY 2022 Q3—
FY 2022 Q4—
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q4—
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q4—
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$40.9M
Biogen capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q2UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FY 2009 Q361.21% · $181.85M0% · $0M38.79% · $115.262MUnavailableUnavailable100% · $297.112M
FY 2009 Q47.41% · $55.517M0% · $0M92.59% · $693.539MUnavailableUnavailable100% · $749.056M
FY 2010 Q15.83% · $38.209M6.1% · $39.976M88.08% · $577.58MUnavailableUnavailable100% · $655.765M
FY 2010 Q24.36% · $47.051M0% · $0M95.64% · $1,031.754MUnavailableUnavailable100% · $1,078.805M
FY 2010 Q37.68% · $38.96M0% · $0M92.32% · $468.245MUnavailableUnavailable100% · $507.205M
FY 2010 Q460.04% · $48.835M39.96% · $32.5M0% · $0MUnavailableUnavailable100% · $81.335M
FY 2011 Q114.13% · $32.143MUnavailable85.87% · $195.287MUnavailableUnavailable100% · $227.43M
FY 2011 Q222.04% · $54.086MUnavailable77.96% · $191.288MUnavailableUnavailable100% · $245.374M
FY 2011 Q3100% · $51.349MUnavailable0% · $0MUnavailableUnavailable100% · $51.349M
FY 2011 Q437.7% · $70.442M2.68% · $5M59.62% · $111.4MUnavailableUnavailable100% · $186.842M
FY 2012 Q19.24% · $54.551M12.27% · $72.401M78.49% · $463.171MUnavailable0% · $0M100% · $590.123M
FY 2012 Q214.03% · $72.896M0% · $0M85.97% · $446.78MUnavailable0% · $0M100% · $519.676M
FY 2012 Q352.18% · $58.064M0% · $0M47.82% · $53.22MUnavailable0% · $0M100% · $111.284M
FY 2012 Q474.23% · $69.037M0% · $0M23.16% · $21.544MUnavailable2.61% · $2.428M100% · $93.009M
FY 2013 Q16.35% · $33.289M0% · $0M7.82% · $41.023MUnavailable85.83% · $450M100% · $524.312M
FY 2013 Q295.86% · $54.151M0% · $0M0% · $0MUnavailable4.14% · $2.34M100% · $56.491M
FY 2013 Q3100% · $80.188M0% · $0MUnavailableUnavailable0% · $0M100% · $80.188M
FY 2013 Q483.98% · $78.653M16.02% · $15M0% · $0.001MUnavailable0% · $0M100% · $93.654M
FY 2014 Q168.48% · $54.306M31.52% · $25M0% · $0MUnavailable0% · $0M100% · $79.306M
FY 2014 Q215.96% · $64.002M0% · $0M84.04% · $336.905MUnavailable0% · $0M100% · $400.907M
FY 2014 Q326.25% · $62.546M62.95% · $150M9.68% · $23.076MUnavailable1.12% · $2.674M100% · $238.296M
FY 2014 Q416.87% · $106.897MUnavailable83.13% · $526.798MUnavailable0% · $0M100% · $633.695M
FY 2015 Q132.98% · $97.83M67.02% · $198.798MUnavailableUnavailableUnavailable100% · $296.628M
FY 2015 Q2100% · $129.858M0% · $0MUnavailableUnavailableUnavailable100% · $129.858M
FY 2015 Q37.2% · $229.197M0% · $0M92.8% · $2,955.997MUnavailableUnavailable100% · $3,185.194M
FY 2015 Q48.51% · $186.115M0% · $0.002M91.49% · $2,001.81MUnavailableUnavailable100% · $2,187.927M
FY 2016 Q1100% · $126.9M0% · $0M0% · $0MUnavailableUnavailable100% · $126.9M
FY 2016 Q2100% · $136.8M0% · $0M0% · $0MUnavailableUnavailable100% · $136.8M
FY 2016 Q332.8% · $170.3M0% · $0M67.2% · $348.9MUnavailableUnavailable100% · $519.2M
FY 2016 Q421.86% · $182.1M0% · $0M78.14% · $651.1MUnavailableUnavailable100% · $833.2M
FY 2017 Q126.46% · $210MUnavailable73.54% · $583.6MUnavailableUnavailable100% · $793.6M
FY 2017 Q220.18% · $197.7MUnavailable79.82% · $781.8MUnavailableUnavailable100% · $979.5M
FY 2017 Q3100% · $229.1MUnavailable0% · $0MUnavailableUnavailable100% · $229.1M
FY 2017 Q4100% · $230.6MUnavailable0% · $0MUnavailableUnavailable100% · $230.6M
FY 2018 Q143.78% · $194.7MUnavailable56.22% · $250MUnavailableUnavailable100% · $444.7M
FY 2018 Q26.36% · $186.8MUnavailable93.64% · $2,750MUnavailableUnavailable100% · $2,936.8M
FY 2018 Q3100% · $163.2M0% · $0M0% · $0MUnavailableUnavailable100% · $163.2M
FY 2018 Q414.31% · $225.9M0% · $0M85.69% · $1,352.6MUnavailableUnavailable100% · $1,578.5M
FY 2019 Q116.23% · $127.1MUnavailable83.77% · $655.8MUnavailableUnavailable100% · $782.9M
FY 2019 Q27.22% · $186.9MUnavailable92.78% · $2,401.5MUnavailableUnavailable100% · $2,588.4M
FY 2019 Q311.15% · $90.1M0% · $0M88.85% · $717.9MUnavailable0% · $0M100% · $808M
FY 2019 Q45.01% · $110.4M0% · $0M94.99% · $2,093.1MUnavailableUnavailable100% · $2,203.5M
FY 2020 Q16.32% · $149.7MUnavailable93.68% · $2,220.2MUnavailable0% · $0M100% · $2,369.9M
FY 2020 Q23.6% · $105MUnavailable96.4% · $2,808.9MUnavailable0% · $0M100% · $2,913.9M
FY 2020 Q36.3% · $84.1MUnavailable93.7% · $1,250MUnavailable0% · $0M100% · $1,334.1M
FY 2020 Q44.33% · $86MUnavailable20.14% · $400MUnavailable75.53% · $1,500M100% · $1,986M
FY 2021 Q110.74% · $92.6MUnavailable69.61% · $600MUnavailable19.64% · $169.3M100% · $861.9M
FY 2021 Q213.76% · $71.9MUnavailable86.11% · $450MUnavailable0.13% · $0.7M100% · $522.6M
FY 2021 Q35.3% · $42MUnavailable94.7% · $750MUnavailable0% · $0M100% · $792M
FY 2021 Q4100% · $51.6MUnavailable0% · $0MUnavailableUnavailable100% · $51.6M
FY 2022 Q16.87% · $36.9MUnavailable93.13% · $500MUnavailable0% · $0M100% · $536.9M
FY 2022 Q34.51% · $59.1MUnavailable19.07% · $250MUnavailable76.43% · $1,002.2M100% · $1,311.3M
FY 2022 Q4100% · $86.4MUnavailable0% · $0MUnavailableUnavailable100% · $86.4M
FY 2023 Q1100% · $66.6MUnavailableUnavailableUnavailable0% · $0M100% · $66.6M
FY 2023 Q2100% · $71MUnavailableUnavailableUnavailable0% · $0M100% · $71M
FY 2023 Q331.7% · $74.2MUnavailable0% · $0MUnavailable68.3% · $159.9M100% · $234.1M
FY 2023 Q44.99% · $65.2M45.22% · $590.5M0% · $0MUnavailable49.78% · $650M100% · $1,305.7M
FY 2024 Q110.29% · $45.9MUnavailableUnavailableUnavailable89.71% · $400M100% · $445.9M
FY 2024 Q211.82% · $33.5MUnavailableUnavailableUnavailable88.18% · $250M100% · $283.5M
FY 2024 Q3100% · $35MUnavailableUnavailableUnavailable0% · $0M100% · $35M
FY 2024 Q4100% · $39.3M0% · $0MUnavailableUnavailable0% · $0M100% · $39.3M
FY 2025 Q1100% · $37.1MUnavailableUnavailableUnavailable0% · $0M100% · $37.1M
FY 2025 Q21.5% · $26.6MUnavailableUnavailableUnavailable98.5% · $1,750M100% · $1,776.6M
FY 2025 Q3100% · $46.2MUnavailableUnavailableUnavailable0% · $0M100% · $46.2M
FY 2025 Q4100% · $43.9MUnavailableUnavailableUnavailable0% · $0M100% · $43.9M
FY 2026 Q1100% · $51.2MUnavailableUnavailableUnavailableUnavailable100% · $51.2M
FY 2026 Q2100% · $40.9MUnavailableUnavailableUnavailableUnavailable100% · $40.9M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Biogen.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources